Dragon Pharma Tesamorelin
Tesamorelin 5 mg represents a clinically-validated, pharmaceutical-grade Growth Hormone Releasing Hormone (GHRH) analog specifically engineered for visceral fat reduction and body composition optimization. As the active pharmaceutical ingredient in the FDA-approved drug Egrifta®, Tesamorelin offers athletes and bodybuilders a scientifically-proven method to target stubborn abdominal adipose tissue while supporting lean muscle preservation and metabolic enhancement. This 44-amino acid peptide analog of human GHRH stimulates natural growth hormone secretion through pituitary receptor activation, creating a sustained elevation of endogenous GH and IGF-1 levels without the risks associated with exogenous hormone administration.
Each vial contains 5 mg of pharmaceutical-grade Tesamorelin Acetate in lyophilized form, providing athletes with a potent tool for contest preparation, cutting phases, and metabolic optimization. Unlike synthetic HGH which can suppress natural production and cause insulin resistance, Tesamorelin works through physiological feedback mechanisms that maintain the body's natural pulsatile GH secretion patterns while specifically upregulating lipolysis in visceral adipose depots. This targeted action makes it particularly valuable for athletes struggling with stubborn abdominal fat that resists traditional diet and exercise approaches.
The performance benefits for physique athletes are substantial: significant reduction in visceral and subcutaneous abdominal fat, improved insulin sensitivity and glucose metabolism, enhanced protein synthesis for muscle preservation during cuts, improved sleep quality and recovery capacity, potential cardiovascular benefits through lipid profile improvement, and superior nutrient partitioning for better body composition outcomes. Additionally, Tesamorelin may support cognitive function and skin quality—valuable secondary effects for competitors during demanding preparation phases.
Dragon Pharma's Tesamorelin is synthesized in EU-certified GMP facilities under strict quality controls ensuring >99% purity, accurate 5 mg dosage per vial, and absence of endotoxins or contaminants. The lyophilization process guarantees extended stability and maintains peptide integrity for optimal biological activity upon reconstitution. With robust clinical data from Phase III trials demonstrating significant visceral fat reduction in diverse populations, athletes can trust in a peptide with proven efficacy and safety profiles.
Key Benefits:
- Targeted Visceral Fat Reduction: Clinically proven to specifically reduce abdominal adipose tissue while preserving lean mass.
- Physiological GH Elevation: Stimulates natural growth hormone secretion without suppressing endogenous production.
- Improved Metabolic Profile: Enhances insulin sensitivity, glucose disposal, and lipid metabolism for better health markers.
- Muscle Preservation Support: Creates anabolic environment that helps maintain lean tissue during calorie restriction.
- FDA-Approved Efficacy: Backed by extensive clinical research and regulatory approval for fat reduction indications.
Each vial contains 5 mg of high-purity Tesamorelin Acetate peptide, manufactured under strict quality control standards in Dragon Pharma's certified facilities. Reconstitute with bacteriostatic water for subcutaneous administration to optimize body composition and target stubborn abdominal fat.
Product Specifications
| Product Name |
Tesamorelin 5 mg |
| Manufacturer |
Dragon Pharma |
| Substance |
Tesamorelin Acetate (GHRH analog) |
| Packaging |
2 mL glass vial (lyophilized powder) |
| Lab Test Result |
Batch-tested for purity & concentration |
| Half-Life |
Approximately 26-38 minutes (sustained effects via GH elevation) |
| Recommended Cycle |
3-6 months for optimal body composition changes |
| Form |
Lyophilized powder for subcutaneous injection |
| Aromatization |
None (peptide hormone secretagogue) |
| Dosage (Men) |
1-2 mg daily, typically administered before bedtime |
Usage Guidelines
Reconstitution: Add 2 mL of bacteriostatic water to the 5 mg vial, yielding 2.5 mg/mL concentration. Gently swirl until completely dissolved—avoid shaking vigorously. For precise dosing, additional diluent may be added. Use within 30 days after reconstitution when refrigerated.
Administration: Subcutaneous injection in abdominal, thigh, or tricep adipose tissue. Best administered before bedtime to align with natural nocturnal GH pulses. Rotate injection sites regularly to prevent lipohypertrophy. Due to Tesamorelin's relatively short half-life, consistent daily administration is crucial for sustained effects.
- Beginner Cycle (Month 1-2): 1 mg daily before bedtime. Assess tolerance and initial metabolic response. Ideal alongside foundational supplements like AOD 9604 5 mg for enhanced fat burning or L-Carnitine 500 for fat transport support.
- Intermediate Cycle (Month 3-4): 1.5 mg daily, consistently before sleep. For active cutting phases or contest prep. Stack with Masteron 200 for hardness or Anavar 50 for muscle preservation during aggressive deficits.
- Advanced Cycle (Month 5-6+): 2 mg daily, occasionally split (pre-bed + morning). For competitors or extreme recomposition goals. Combine with Trenbolone 100 for extreme fat loss or IGF-1 LR3 for localized growth enhancement.
Post Cycle Therapy (PCT):
Tesamorelin is excellent during PCT to maintain metabolic rate, support recovery, and prevent fat regain after anabolic cycles. Continue throughout PCT at 1-1.5 mg daily. Pair with Nolvadex or Aromasin for comprehensive hormonal recovery support.
Liver Protection & Metabolic Support:
Tesamorelin presents no hepatotoxicity and may improve liver enzymes through visceral fat reduction. However, athletes using oral steroids should implement standard liver protection with liver support supplements. Monitor glucose levels as Tesamorelin can improve insulin sensitivity.
Storage Instructions
Unreconstituted (Lyophilized Powder): Store at 2-8°C (36-46°F) in refrigerator. Keep in original packaging protected from light. Shelf life: 24 months from manufacture date when stored properly. Avoid temperature fluctuations above 25°C to maintain peptide integrity.
After Reconstitution: Refrigerate immediately at 2-8°C (36-46°F). Use within 30 days. Do not freeze reconstituted solution. If solution becomes cloudy or contains particles, discard immediately. For travel, use insulated cooler with ice packs.
Handling Best Practices: Maintain aseptic technique throughout. Clean work surface, wash hands, wear gloves if possible. Wipe rubber stopper with alcohol swab before each puncture. Use sterile syringes and bacteriostatic water only. Never reuse needles.
What is tesamorelin peptide used for in bodybuilding?
Tesamorelin is a GHRH analog used for visceral fat reduction, improved body composition, muscle growth support, enhanced recovery, and metabolic optimization. It's particularly effective for targeting stubborn abdominal fat while preserving lean mass. With FDA approval for lipodystrophy, it has strong clinical evidence for body recomposition.
How long does it take for tesamorelin to start working?
Initial effects appear within 2-4 weeks, with significant body composition changes visible by 8-12 weeks. Full benefits typically manifest after 3-6 months of consistent use. Visceral fat reduction continues improving with prolonged administration. Maximum results are achieved with sustained 6-month cycles.
How does Dragon Pharma Tesamorelin differ from Ipamorelin?
Tesamorelin is a GHRH analog (growth hormone releasing hormone) that provides sustained GH elevation, while Ipamorelin is a GHRP (growth hormone releasing peptide) that creates pulsatile GH release. Tesamorelin is FDA-approved for fat loss and has stronger clinical data for visceral fat reduction. Many athletes stack both for comprehensive effects.
Can Tesamorelin be stacked with other Dragon Pharma peptides?
Yes, Tesamorelin stacks well with Ipamorelin for amplified GH release, with AOD-9604 for enhanced fat burning, or with BPC-157 for improved recovery. Dragon Pharma also offers a combined Ipamorelin/Tesamorelin product for synergistic effects. Stacking with GHRP-6 can further enhance GH pulsatility.
Is Tesamorelin better for fat loss than traditional GHRPs?
For visceral fat specifically, Tesamorelin has superior clinical evidence. While GHRPs like Ipamorelin increase overall GH, Tesamorelin's GHRH action targets abdominal fat more effectively. Many athletes use both for comprehensive body recomposition—GHRPs for general benefits, Tesamorelin for targeted abdominal reduction.
February 4, 2026
Used during my prep for a classic physique show. Lost 4 inches off my waist while maintaining all my muscle. The abdominal definition was incredible.